Adalimumab, sold under the brand name Humira, was approved for use in the United States in 2002. Adalimumab, sold under the brand names Humira and Trudexa, was approved for use in the European Union in September 2003 .
25 авг. 2022 г. · Humira FDA Approval History. Last updated by Judith Stewart, BPharm on Aug 25, 2022. FDA Approved: Yes (First approved December 31, 2002) |
AbbVie's HUMIRA® (adalimumab) Receives U.S. Food and ... news.abbvie.com › 2016-06-30-AbbVies-HUM...
30 июн. 2016 г. · In 2014, the FDA granted HUMIRA orphan drug designation for the treatment of certain forms of uveitis, which affect a population of fewer than ... |
10 сент. 2015 г. · In July, the European Commission approved HUMIRA ... Since first gaining approval 12 years ago, HUMIRA has been approved in more than 87 countries ... |
28 сент. 2012 г. · "Since the first FDA approval of HUMIRA in late 2002, Abbott has continued to investigate the medication in multiple conditions with the goal of ... |
Humira (Adalimumab) Injection Company: Abbott Laboratories Application No.: 125057s0110. Approval Date: 01/18/2008 · Chemistry Review(s) · Environmental ... |
16 июн. 2016 г. · In 2014, the FDA granted HUMIRA orphan drug designation for the treatment of certain forms of uveitis, which affect a population of fewer than ... |
In studies in adults with ulcerative colitis, Humira produced a greater improvement in symptoms and healing of the mucosa (the lining of the gut) than placebo. |
Humira (also know by its generic name adalimumab) is a TNF-alpha inhibitor biologic approved by the FDA in October 2005 for use in adult patients to treat ... |
| Novbeti > |
| Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |